be_ixf;ym_202512 d_14; ct_50
CIT charts & data provided by TradingView

Latest Insights on CIT

Bitcoin has no central bank and a hard cap on the amount that can exist. It has rapidly become an alternative to fiat currency. Bitcoin Soars 300% — Ultimate Hedge Against Central Banks June 28, 2019 by Ian King Currency, Global Economy, Winning Investor Daily Bitcoin has no central bank and a hard cap on the amount that can exist. It has rapidly become an alternative to fiat currency.
Great Stuff 6-28-2019 G-20 Weekend: 4 Things You Need to Know June 28, 2019 by Joseph Hargett Great Stuff It’s G-20 weekend! Aren’t you excited? World leaders are gathering in Osaka, Japan, to discuss how best to take advantage of each other and you, the investor. It’s kind of like Family Feud, except on a global scale. For a closer look at this growing kerfuffle, here’s your Friday Four Play: Russian President Vladimir Putin […]
Great Stuff 6-27-2019 Bitcoin’s Crypto Bubble, Thanks to Facebook Libra June 27, 2019 by Joseph Hargett Great Stuff Today, we’re not going to talk about Trump, China or the Democratic debates. You’re welcome. The reason: I’m plumb Xi’ed out. I’ve got no more Trump in the tank, and it’s far too early to worry about what the two million candidates running for the Democratic nomination are debating right now. Besides, bitcoin (CCC: BTC-USD) […]
ROBO ETF Is a Great Way to Invest in the Emerging Tech Revolution June 27, 2019 by Charles Mizrahi American Investor Today, Investment Opportunities, Technology Electricity changed the world forever. It would be very difficult for our modern society to exist without it. Nowadays, there is a new trend that’s already changing our way of living. Charles Mizrahi has a close eye on this profitable sector. (3-minute read)
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

Share This